Anti-ERLEC1 antibody [EPR13849] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal ERLEC1 antibody. Carrier free. Suitable for WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
C2orf30, XTP3TPB, UNQ1878/PRO4321, ERLEC1, Endoplasmic reticulum lectin 1, ER lectin, XTP3-transactivated gene B protein, Erlectin
- WB
Supplier Data
Western blot - Anti-ERLEC1 antibody [EPR13849] - BSA and Azide free (AB250392)
This data was developed using ab181166, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-ERLEC1 antibody [EPR13849] (<a href='/en-us/products/primary-antibodies/erlec1-antibody-epr13849-ab181166'>ab181166</a>) at 1/2000 dilution
All lanes:
A375 lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 55 kDa
false
- WB
Supplier Data
Western blot - Anti-ERLEC1 antibody [EPR13849] - BSA and Azide free (AB250392)
This data was developed using ab181166, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-ERLEC1 antibody [EPR13849] (<a href='/en-us/products/primary-antibodies/erlec1-antibody-epr13849-ab181166'>ab181166</a>) at 1/10000 dilution
All lanes:
HepG2 lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 55 kDa
false
Reactivity data
Product details
ab250392 is the carrier-free version of ab181166.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ERLEC1 contributes to the ER-associated degradation (ERAD) pathway by interacting with other ER chaperones and lectin-like proteins. ERLEC1 forms part of a protein complex that identifies misfolded glycoproteins and targets them for degradation. Its function is important for relieving the ER of protein overload therefore maintaining cellular homeostasis. This role is particularly significant in tissues with high protein synthesis rates such as the liver and pancreas.
Pathways
ERLEC1 plays an important role in the unfolded protein response (UPR) by assisting in the degradation of malfunctioning proteins. It interacts with other proteins such as HRD1 and SEL1L which are part of the ERAD pathway to achieve this function. ERLEC1 contributes to maintaining cellular health by ensuring only correctly folded proteins proceed to their destination therefore preventing stress induced by protein aggregation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Evidence-based complementary and alternative medicine : eCAM 2022:7757833 PubMed36091585
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com